Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
CSPC Pharmaceutical Group ( (HK:1093) ) just unveiled an announcement.
CSPC Pharmaceutical Group Limited announced the on-market purchase of 504,000 shares as part of its restricted share award scheme. This move, involving a total consideration of approximately HK$4,483,000, represents about 0.004% of the company’s existing shares and is intended to benefit selected participants, potentially enhancing stakeholder engagement and company performance.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a company incorporated in Hong Kong, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and marketing of pharmaceutical products.
Average Trading Volume: 171,365,944
Technical Sentiment Signal: Buy
Current Market Cap: HK$108.8B
See more data about 1093 stock on TipRanks’ Stock Analysis page.